WallStreetZenWallStreetZen

NASDAQ: ANAB
Anaptysbio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ANAB

Based on 5 analysts offering 12 month price targets for Anaptysbio Inc

Min Forecast
$20.00-1.62%
Avg Forecast
$54.60+168.57%
Max Forecast
$90.00+342.7%

Should I buy or sell ANAB stock?

Based on 5 analysts offering ratings for Anaptysbio Inc.

Buy
Strong Buy
2 analysts 40%
Buy
2 analysts 40%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ANAB's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ANAB as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ANAB stock forecasts and price targets.

ANAB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-12
lockedlocked$00.00+00.00%2025-08-07
lockedlocked$00.00+00.00%2025-07-24
lockedlocked$00.00+00.00%2025-06-04
lockedlocked$00.00+00.00%2025-05-28

1 of 1

Forecast return on equity

Is ANAB forecast to generate an efficient return?

Forecast return on assets

Is ANAB forecast to generate an efficient return on assets?

Company
-42.21%
Industry
45.93%
ANAB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ANAB earnings per share forecast

What is ANAB's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$4.71
Avg 2 year Forecast
-$5.09
Avg 3 year Forecast
-$5.46

ANAB revenue forecast

What is ANAB's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$104.2M-15.43%
Avg 2 year Forecast
$119.7M-2.81%
Avg 3 year Forecast
$134.8M+9.44%
ANAB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ANAB revenue growth forecast

How is ANAB forecast to perform vs Biotechnology companies and vs the US market?

Company
3.08%
Industry
83.25%
Market
10.49%
ANAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ANAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ANAB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANAB$20.33$54.60+168.57%Buy
ARVN$7.73$15.19+96.56%Buy
SVRA$3.28$5.00+52.44%Buy
GOSS$2.47$8.50+244.13%Strong Buy
XNCR$8.13$18.50+127.55%Buy
View Top Biotech Stocks

Anaptysbio Stock Forecast FAQ

Is Anaptysbio Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: ANAB) stock is to Buy ANAB stock.

Out of 5 analysts, 2 (40%) are recommending ANAB as a Strong Buy, 2 (40%) are recommending ANAB as a Buy, 1 (20%) are recommending ANAB as a Hold, 0 (0%) are recommending ANAB as a Sell, and 0 (0%) are recommending ANAB as a Strong Sell.

If you're new to stock investing, here's how to buy Anaptysbio stock.

What is ANAB's earnings growth forecast for 2025-2027?

(NASDAQ: ANAB) Anaptysbio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.22%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.8%.

Anaptysbio's earnings in 2025 is -$132,594,000.On average, 8 Wall Street analysts forecast ANAB's earnings for 2025 to be -$131,725,711, with the lowest ANAB earnings forecast at -$174,421,079, and the highest ANAB earnings forecast at -$56,833,835. On average, 8 Wall Street analysts forecast ANAB's earnings for 2026 to be -$142,504,542, with the lowest ANAB earnings forecast at -$228,175,248, and the highest ANAB earnings forecast at -$33,036,416.

In 2027, ANAB is forecast to generate -$152,807,424 in earnings, with the lowest earnings forecast at -$285,009,083 and the highest earnings forecast at -$38,915,779.

What is ANAB's revenue growth forecast for 2025-2027?

(NASDAQ: ANAB) Anaptysbio's forecast annual revenue growth rate of 3.08% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 83.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.49%.

Anaptysbio's revenue in 2025 is $123,164,000.On average, 7 Wall Street analysts forecast ANAB's revenue for 2025 to be $2,916,191,663, with the lowest ANAB revenue forecast at $1,400,688,059, and the highest ANAB revenue forecast at $4,139,071,010. On average, 6 Wall Street analysts forecast ANAB's revenue for 2026 to be $3,351,376,456, with the lowest ANAB revenue forecast at $1,119,878,520, and the highest ANAB revenue forecast at $6,439,301,490.

In 2027, ANAB is forecast to generate $3,773,710,643 in revenue, with the lowest revenue forecast at $2,371,342,766 and the highest revenue forecast at $5,067,450,303.

What is ANAB's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ANAB) forecast ROA is -42.21%, which is lower than the forecast US Biotechnology industry average of 45.93%.

What is ANAB's Price Target?

According to 5 Wall Street analysts that have issued a 1 year ANAB price target, the average ANAB price target is $54.60, with the highest ANAB stock price forecast at $90.00 and the lowest ANAB stock price forecast at $20.00.

On average, Wall Street analysts predict that Anaptysbio's share price could reach $54.60 by Aug 12, 2026. The average Anaptysbio stock price prediction forecasts a potential upside of 168.57% from the current ANAB share price of $20.33.

What is ANAB's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ANAB) Anaptysbio's current Earnings Per Share (EPS) is -$4.42. On average, analysts forecast that ANAB's EPS will be -$4.71 for 2025, with the lowest EPS forecast at -$6.23, and the highest EPS forecast at -$2.03. On average, analysts forecast that ANAB's EPS will be -$5.09 for 2026, with the lowest EPS forecast at -$8.15, and the highest EPS forecast at -$1.18. In 2027, ANAB's EPS is forecast to hit -$5.46 (min: -$10.18, max: -$1.39).

What is ANAB's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ANAB) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.